Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
Moodys
Harvard Business School
Mallinckrodt

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

SPECTROBID Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Spectrobid, and when can generic versions of Spectrobid launch?

Spectrobid is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in SPECTROBID is bacampicillin hydrochloride. There are two drug master file entries for this compound. Additional details are available on the bacampicillin hydrochloride profile page.

Summary for SPECTROBID
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 27
Patent Applications: 673
DailyMed Link:SPECTROBID at DailyMed
Drug patent expirations by year for SPECTROBID
Synonyms for SPECTROBID
(2S,5R,6R)-6-((R)-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with ethyl 1-hydroxyethyl carbonate, monohydrochloride
(2S,5R,6R)-6-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 1-ethoxycarbonyloxyethyl ester hydrochloride
1-((Ethoxycarbonyl)oxy)ethyl (2S-(2alpha,5alpha,6beta(S*)))-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrochloride
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
1-ethoxycarbonyloxyethyl (2S,5R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
37661-08-8
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, hydrochloride
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, monohydrochloride, (2S-(2alpha,5alpha,6beta(S*)))-
50972-17-3 (Parent)
6-[(r)-2-amino-2-phenylacetamido]penicillanic acid[1-(ethoxycarbonyloxy)ethyl] ester monohydrochloride
A823813
AC1L2G5H
AC1L9B3G
AC1Q5YDU
AKOS016014246
Ambacamp
Ambaxin
API0000413
AX8020538
Bacacil
Bacampicillin (hydrochloride)
bacampicillin HCl
Bacampicillin hydrochloride
Bacampicillin hydrochloride (JP17/USP)
Bacampicillin hydrochloride [USAN:JAN]
Bacampicillin hydrochloride [USAN:USP:JAN]
Bacampicillin hydrochoride
BAPC
C08123
C21H27N3O7S.HCl
CAS-37661-08-8
CCG-220416
CHEBI:2969
CHEMBL1200965
CS-4754
D00927
DSSTox_CID_25466
DSSTox_GSID_45466
DSSTox_RID_80897
DTXSID0045466
EINECS 253-580-4
HMS1569C14
HY-B1149A
IWVTXAGTHUECPN-ANBBSHPLSA-N
LS-149733
MLS002153801
MolPort-019-996-595
NCGC00016837-01
NCGC00179582-03
Penglobe
PM034U953T
Prestwick_776
SCHEMBL124593
SMR001233177
Spectrobid (TN)
SureCN721373
Tox21_110640
Tox21_110640_1
UNII-PM034U953T
Velbacil

US Patents and Regulatory Information for SPECTROBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer SPECTROBID bacampicillin hydrochloride FOR SUSPENSION;ORAL 050556-001 Mar 23, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer SPECTROBID bacampicillin hydrochloride TABLET;ORAL 050520-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer SPECTROBID bacampicillin hydrochloride TABLET;ORAL 050520-002 Sep 12, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Harvard Business School
Express Scripts
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.